Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics for Wound Complications After Vulvectomy
NCT00550290Phase 4Completed
- Sponsor
- Aultman Health Foundation
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in Wound infection (WI), sponsored by Aultman Health Foundation. Started Oct 2007; status: completed.
02
Drugs
cefazolin
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on NCT00550290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550290.